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Hormonal Regulation of Lipolysis and
Phosphorylase Activity in Human Fat Cells
JAY MOSKOWrrz and JoH N. FAIN
From the Division of Biological and Medical Sciences, Brown University,
Providence, Rhode Island 02912

A B S T R A C T Prostaglandin El (PGE1) at a concentration of 1 ng/ml antagonized theophylline, and norepinephrine induced release of glycerol and free fatty
acids (FFA) in human fat cell preparations. Insulin
at higher doses also inhibited theophylline-stimulated
lipolysis. The N6-2-O'dibutyryl derivative of cyclic
adenosine monophosphate (DCAMP) stimulated lipolysis. Prostaglandin E1 did not significantly inhibit the
lipid mobilizing effects of DCAMP. Changes in glycogen phosphorylase activity after treatment with theophylline, norepinephrine, DCAMP, and PGE1 paralleled
those of lipolysis. These results suggest that in man
as in experimental animals lipolysis and phosphorylase
activity are regulated through processes involving cyclic
AMP and that PGEi appears to exert its antilipolytic
effect in human fat cells, as in rat fat cells, by interfering at the level of adenyl cyclase with the accumulation of cyclic AMP.

INTRODUCTION
Lipid mobilization is primarily controlled by the rate of
hydrolysis of the triglyceride stores of the fat cells of
adipose tissue (1). Catecholamines stimulate free fatty
acid (FFA) mobilization by activating adenyl cyclase,
an enzyme involved in the production of 3',5'-cyclic
adenosine monophosphate (AMP) (2). Methylxanthines are thought to potentiate lipolysis by inhibiting
the cyclic nucleotide phosphodiesterase, the enzyme
responsible for the distruction of 3',5'-cyclic AMP (2,
3). The accumulation of the cyclic AMP presumably
activates an inactive lipase which hydrolyzes triglycerides (4).
A preliminary report of these studies was presented at
the December 1968 meeting of the Eastern Section of the
American Federation for Clinical Research.
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Prostaglandin E, (PGE,) has been found to antagonize the in vitro stimulation by catecholamines and
theophylline of lipolysis in rat adipose tissue (5-7). In
man, the infusion of PGE1 causes a rise in plasma free
fatty acids (8). It was originally reported that PGE1
in vitro reduced basal lipolysis, but not that due to
catecholamines in human adipose tissue (9). Recently
Carlson and Hallberg (10) were able to show partial
inhibition of catecholamine-induced lipolysis by PGE1
in subcutaneous and omental human adipose tissue slices.
The present studies were designed to test the possibility that cyclic AMP is involved in human fat cell
lipolysis and glycogenolysis. These studies suggest that
the actions of prostaglandin Ei, methylxanthines, catecholamines, and dibutyryl cyclic AMP (DCAMP) on
these processes in human fat cells are quite similar to
the effects which have been observed with fat cells
from rats.

METHODS
Human adipose tissue was obtained during the course of
abdominal surgery. Severely obese patients and those
with diabetes and jaundice were excluded. Preparative
treatment included an overnight fast and medication with
Nembutal, Demerol, and scopolamine. Patients were given
either spinal or general anesthesia or both. Adipose tissue
samples were usually obtained fronm the abdominal wall
just before closure of the wound. Within 5 min after removal the tissue was placed in 0.9%o saline (37'C) and cut
into small pieces. Connective tissue was removed and the
tissue was incubated in saline for several minutes at 37°C.
The pieces of adipose tissue were then removed and placed in
plastic bottles for collagenase digestion. Rat white fat cells
were isolated from the parametrial and periovarian adipose tissue of immature female rats (Sprague-Dawley, CD,
Charles River Breeding Laboratories) The rats were fed
ad lib. on laboratory chow and sacrificed by decapitation.
The cells were isolated by a modification of the procedure of Rodbell (11) in 4% albumin solution (bovine fraction V albumin powder obtained from the Pentex, Inc., Kankakee, Ill. (P-55) (Fig. 4 only) or the Armour Pharmaceutical Co., Chicago, Ill.) (A-27) made up fresh daily
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FIGURE 1 Inhibition by prostaglandin E1 of the lipolytic action of norepinephrine on isolated
human fat cells. Free fat cells (35.6 ,umoles triglyceride/flask) were incubated for 4 hr in 1.5
ml of 4% albumin (A-27) in buffer without added glucose. Prostaglandin E1 and norepinephrine bitartrate (arterenol) were added at the start of the incubation. Each point is the mean
of eight paired experiments. Prostaglandin E1 at concentrations of 1 ng/ml or greater significantly inhibited the increase in lipolysis due to all doses of arterenol (P < 0.05 by paired

comparisons).
in phosphate buffer. The phosphate buffer contained: NaCl,
129 mmoles/liter KC1 5.15 mmoles/liter; CaCl2 1.39
mmoles/liter; MgSO4 1.4 mmoles/liter; and Na2HPO4, 10
mmoles/liter. The pH was adjusted to 7.4 with NaOH.
Pieces of adipose tissue were placed in 1-ounce plastic
bottles containing 3 ml of 4%o albumin in buffer and 1.5 mg

of crude bacterial collagenase (Clostridium histolyticum,
Worthington Biochemical Corp., Freehold, N. J.), incubated for 1 hr at 37C in a Dubnoff metabolic shaker and
then filtered through nylon chiffon to remove any remaining
stromal material and undigested adipose tissue. The separated cells were washed three times in l1% albumin in
buffer and resuspended in 4%o albumin in buffer for incubation studies.
In all studies the fat cells were incubated in 17 X 100
mm plastic culture tubes. Initial control values were obtained on cells incubated for 5 min. The values for glycerol
and fatty acid release in each experiment were the average
of duplicate tubes, except for studies in which phosphorylase
activity was measured which were done in quadruplicate,
using pooled fat cells obtained from a single patient or
three rats. All experiments were replicated from five to
eight times and each replication was done on a separate

day. Glycerol was determined on either a 50 or 100 /Al
aliquot of the medium by a micromodification of the enzymatic procedure of Vaughan (12) in which diphosphopyridine
nucleotide (DPNH) formation was measured with a filter
fluorometer (American Instrument Co. Inc., Silver Springs,
Md.) Free fatty acids were determined on the remainder
of the incubation medium by a modification of the procedure of Dole and Meinertz (13) in which hexane was substituted for heptane. Phosphorylase activity was determined
by a modification of the procedure of Diamond- and
Brody (14). After the incubation period, the fat cells from
the four tubes for each point were separated by centrifugation
from the albumin-containing medium, resuspended in 2 ml
of cold (0°-50C) 50 mm Tris buffer (pH 6.8) containing
1 mM ethylenediaminetetraacetate (EDTA), 20 mm NaF,
and 0.3% albumin, and homogenized immediately with a
Potter-Elvehjem homogenizer (Teflon pestle). After centrifugation at 26,000 g for 10 min at 00C, 0.2 ml aliquots of
the infranatant, the soluble layer between the pellet and the
fat cake, were incubated in 50 mm Tris buffer pH 6.8, 0.4%
glycogen, 10 mm glucose-i-phosphate, 1 mm EDTA, 20 mM
NaF, and 0.3%o albumin in a total volume of 1 ml in the
presence and absence of 1 mm AMP. The addition of 5'-AMP
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FIGuRE 2 Inhibition by prostaglandin E1 of the lipolytic action of theophylline on isolated
fat cells. Free fat cells (49.3 /Amoles triglyceride/flask) were incubated for 4 hr in 1.5 ml of 4%o
albumin (A-27) in buffer without added glucose. Prostaglandin E1 and theophylline were added
at the start of the incubation. Each point is the mean of six paired experiments. Prostaglandin
E1 at concentrations of 1 ng/ml or greater significantly inhibited the increase in lipolysis due
to all doses of theophylline (P < 0.05 by paired comparisons).

increased the activity of the phosphorylase. The increment
was, however, the same in the presence of lipolytic and antilipolytic agents. Vaughan (15), working with rat adipose
tissue, reported that the effect of 5-AMP does not seem to
be related to prior treatment of the tissue. At present there
are no quantitative data available concerning the dependence
of various forms of adipose tissue phosphorylase on 5-AMP.
The rate of production of inorganic phosphate was constant
for 30 min in both the presence and absence of AMP. No
phosyphorylase was detected if glycogen was omitted
from the incubation medium. The dependence on glycogen
in the assay system indicates that organic phosphate formation is due to phosphorylase activity rather than nonspecific phosphatase activity.
Prostaglandin El was a gift of Dr. John E. Pike (The
Upjohn Co., Kalamazoo, Mich.); L-norepinephrine bitartrate (arterenol), theophylline, dibutyryl cyclic AMP
(DCAMP), and AMP were obtained commercially. Stock
solutions of these agents were stored at - 15'C. In the
presentation of the data, the arithmetic mean is used.
However, the significance of the differences between the
various experimental pairs was determined by the use of
the Student's t test (16) on the logarithms of the paired
differences. The distribution of the data was not normal, as is
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often the case in biological systems, and for data of this
kind the logarithms are distributed more normally (16).
The original ranges and means were nearly proportional,
but after logarithmic transformations the ranges were
almost equal and uncorrelated with the means.
RESULTS

Low concentrations of norepinephrine bitartrate (arterenol) markedly stimulated lipolysis by human fat
cells (Fig. 1). Maximal stimulation of lipolysis was
seen with 0.2 /Ag/ml of arterenol and a higher concentration actually gave somewhat lower lipolysis as based
on glycerol release.
As little as 1 ng/ml of prostaglandin E1 was able to
inhibit lipolysis due to all concentrations of arterenol
(Fig. 1). Maximal inhibition of the lipolytic action of
arterenol was obtained at PGE1 concentration of 100
ng/ml.
The effect of PGEi on the theophylline-induced lipolysis was similar to that seen with norepinephrine (Fig.

2). The average increase in glycerol release due
to the highest concentration of theophylline in the
studies shown in Fig. 2 was 12.5 Atmoles/mmole triglyceride as contrasted to 10.8 t'moles/mmole triglyceride in the presence of norepinephrine (Fig. 1).
The results in both figures are shown as the per cent
of maximal response, since the per cent differences varied
much less between experiments than the actual differences due to PGE1. Lipolysis was significantly inhibited,
at all doses of theophylline and arterenol, in the presence
of 1 ng/ml or more of PGEL. Insulin had an antilipolytic
action on theophylline-induced lipolysis (Fig. 3). However, the effects of insulin were more variable than those
of PGE1, and only the effect of 100 AU of insulin/ml was
statistically significant.
The addition of the dibutyryl derivative of cyclic
AMP, N6-2-0'-dibutyryl cyclic AMP (DCAMP) increased lipolysis in the human cells (Fig. 4). In experiments with isolated rat fat cells significant increases
in DCAMP-stimulated lipolysis were achieved with
lower concentrations in human cells than in rat fat
cells. The maximal response per millimole of triglyceride
was much greater, however, in the rat fat cells. The
effects of PGEi on the DCAMP-stimulated lipolysis are
given in Table I. While the effects of high doses of
theophylline were markedly inhibited by 100 ng/ml of
PGEi (64% inhibition) PGEi had little or no effect on
DCAMP-stimulated lipolysis.
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FIGuRE 3 The effect of insulin on the lipolytic action of
theophylline in isolated human fat cells. Free fat cells (45.0
umoles triglyceride/flask) were incubated for 4 hr in 1.5 ml
of 4%o albumin (A-27). Theophylline and insulin were added
at the start of the incubation. Each point is the mean of six
paired experiments. Significant effects of insulin are shown
by asterisks (P < 0.05 by paired comparisons).
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FIGuRE 4 Sensitivity of human fat cells to lipolytic action
of dibutyryl cyclic AMP as compared to rat fat cells. Free
rat fat cells (15.7 Amoles triglyceride/flask) and human fat
cells (15.8 Amoles triglyceride/flask) were incubated for
4 hr in 1.5 ml of 4% albumin (P-55) without added glucose.
Dibutyryl cyclic AMP (DCAMP) and theophylline were
added at the start of the incubation period. Each point is the
mean of five paired experiments. The rat and human cells
were incubated at the same time under identical conditions.

To measure the effects of PGE, on a parameter of
cyclic AMP action other than lipolysis, we measured
glycogen phosphorylase activity in extracts of the isolated fat cells. Theophylline and norepinephrine increased
both phosphorylase activity and lipolysis in the human
fat cells (Table II). PGEi inhibited the increase in
phosphorylase activity due to norepinephrine and theophylline, both in the presence and absence of AMP
(Table II). The total lipolytic response due to these
agents were lower than that in our other studies because of the large amount of cells (87.1 ttmoles triglyceride/flask) needed to obtain detectable phosphorylase activity. PGE1 inhibited both phosphorylase
activity and glycerol release in the theophylline and arterenol-stimulated cells.
The effects of PGE, on DCAMP-stimulated lipolysis
and phosphorylase activity were also examined (Table III). Both phosphorylase activity and lipolysis
were stimulated by the addition of DCAMP. Prostaglandin Ei did not affect the stimulation of lipolysis and
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TABLE I

Failure of Prostaglandin E1 to Inhibit the Lipolytic Action
of Dibutyryl Cyclic AMP on Human Fat Cells
Free fatty acid release

TABLE 11
Inhibition by Prostaglandin El of the Activation of Lipolysis
and Phosphorylase by Arterenol and Theophylline

Glycerol release
Basal

Additions

Increment
Increment
due to
due to
lipolytic Inhibition lipolytic Inhibition
agent
by PGEi
by PGE1
agent

jsmoles/mmole
DCAMP
Theophylline
4 mmoles/liter

pmoles/mmole

triglyceride

%

triglyceride

24.5

5 i3

12.5

2 ±3

17.0

61 ±13

8.0

64 4I

%

Free fat cells (36 ,moles triglyceride/tube) were incubated
for 4 hr in 1.5 ml of 4% albumin with the additions added at
the start of incubation period. The values are the means of 5
paired experiments ±SE. Basal release of fatty acid and glycerol were 13 and 1.4 pmoles/mmole triglyceride, respectively.
PGE, concentration, when present, was 100 ng/ml. PGE,
=prostaglandin El; AMP = adenosine monophosphate;
DCAMP = dibutyryl cyclic AMP.

phosphorylase activity by DCAMP while that of theophylline was greatly reduced by PGE1.
DISCUSSION
Previous investigators of human adipose tissue lipolysis have reported a poor response of this tissue to catecholamines (10, 17-19). Galton and Bray (20) have
recently demonstrated that isolated fat cells respond
better than tissue to large quantities of epinephrine.
The isolated fat cells preparations used in this study
responded to low concentrations of catecholamines, since
10-' M norepinephrine significantly increased lipolysis.
Human adipose tissue lipolysis appears to be very
sensitive to the antilipolytic agent, prostaglandin Ei.
Carlson and Hallberg (10) have reported an antilipolytic
effect of PGE, on omental and (less often) subcutaneous
adipose tissue lipolysis stimulated by norepinephrine. A
large dose of PGEi 100 ng/ml was utilized to inhibit the
hormone-stimulated lipolysis and this inhibition was
achieved in only two of the four subcutaneous specimens,
examined (10). The present studies indicate that free
fat cell preparations are very sensitive to PGE1 since
1 ng/ml inhibited norepinephrine-induced lipolysis
(Fig. 1). The responsiveness of the human fat cell
preparations to norepinephrine and PGE1 are similar to
the results of previous observations with rat fat cells
(21).
Theophylline has not been utilized as a lipolytic agent
with human fat cell preparations. In our hands, the
maximal rate of lipolysis in human fat cells seen with
theophylline was about the same as that due to catecholamines. Low doses of theophylline (0.2 mmole/liter)
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+ The+ Arterenol ophylline

Phosphorylase activity in the presence of 1 mM AMP

,umoles phosphate/mmole
triglyceride
6.72
6.92
4.92
5.32
-1.60* -1.80*
Phosphorylase activity in the absence of AMP
No additions
Prostaglandin El
Increment due to PGE1

4.12
3.52
-0.60

Emoles phosphate/mmole
No additions
Prostaglandin El
Increment due to

PGE1

1.64
1.16
-0.48

triglyceride
4.80
2.60

3.72
2.20

-2.20*

-1.52*

Glycerol release
limo~Tles glycerolimmole

triglyceride
No additions
Prostaglandin El
Increment due to PGE,

2.87
2.86
-0.01

4.05
2.90
-1.15*

4. 49
3. ,10
-1.,39*

Human fat cells (87.1 smoles triglyceride/flask) were incubated for 1/2 hr in 1.5 ml of 4%' albumin in buffer without
added glucose. Arterenol (norepinephrine bitartrate) 0.1
Ag/ml, theophylline (1 mmole/liter), and prostaglandin
(PGEO) (100 ng/ml) were added at the start of the incubation
period. The values are shown as the means of 8 paired experiments. The increases due to arterenol and theophylline in the
absence of PGE, are significant (P <0.05).
* A significant effect of PGEI is indicated, P <0.05.

elicited a lipolytic response similar to 0.05 Ag/ml norepinephrine. As was the case with catecholamines, extremely low doses of PGE1 (as low as 1 ng/ml) were
potent inhibitors of theophylline-stimulated lipolysis.
Few reports on insulin as an antilipolytic agent on
human cell lipolysis have appeared except for that of
Galton and Bray (20), who found the human fat cell
response to insulin to be quite erratic. Although insulin at 1000 AU/ml decreased epinephrine-stimulated
lipolysis, the difference was not significant (20).
Burns and Langley (22) have more recently found epinephrine-stimulated lipolysis in human cells to be
inhibited by low doses of insulin. We have also, like
Galton and Bray (20), found the response of human
cells to insulin quite erratic. However, the theophyllinestimulated lipolysis was significantly reduced with 100
AU/ml insulin in our experiments.
Human cells have been shown to be sensitive to insulin as based on stimulation of glucose incorporation
into C02 and fatty acids (23). The sensitivity of the

TABLE I II
The Stimulation of Phosphorylase Activity and Lipolysis
by Dibutyryl Cyclic AMP in Human Fat Cells
Additions

Basal

Increment due
to DCAMP

P value

Phosphorylase activity in the presence of 1 mM AMP
.smoles phosphate/mmole
triglyceride
None
+4.40
0.01
5.76
PGE1
4.72
+4.64
0.05
Theophylline
9.32
+0.68
NS
Theophylline + PGE,
6.16
+2.96
0.01

Glycerol release

Amoles glycerolimmole
None

PGE1
Theophylline
Theophylline + PGEI

2.4t9
2.334
3.229

2.4 6

triglyceiide
+0.87

0..01

+0.56
+0.77
+0.89

0..01
0..05
0.1.01

Free human fat cells (95.6 Mmoles triglyceride/flask) were
incubated for 1/2 hr in 1.5 ml of 4% albumin without added
glucose. Dibutyryl cyclic AMP (0.25 mmole/liter), theophylline (1 mmole/liter), and prostaglandin El (PGE1) (100
ng/ml) were present from the start of the incubation. The
basal values and the increments due to the addition of
DCAMP are shown as the means of 5 paired experiments. The
increment due to DCAMP was not affected by PGE1 either
in the presence or absence of theophylline (P <0.05 by paired
differences which is also used as the criteria for nonsignificant
differences represented by NS).

cells appears to be reduced with age (23) and increased cell size (24). The variations in the antilipolytic
effects of insulin in our studies may be due to high
titers of insulin in the patients' plasma before excision
of the tissue, since the patients in our studies received
a glucose infusion during surgery.
Since both norepinephrine and theophylline are believed to increase the accumulation of cyclic AMP in
the rat fat cell (2), we utilized the N-2-0-dibutyryl
derivative of cyclic AMP (DCAMP) to see if it would
stimulate lipolysis in the human fat cells. Our data
indicate that human adipocytes respond to DCAMP and
are more sensitive to low doses of this compound than
are the rat fat cells. However, high doses of DCAMP
gave a greater stimulation of lipolysis in rat adipocytes
than in human cells. The reason for the 5-fold greater
sensitivity of human fat cells lipolysis to 0.1 mm
DCAMP is not clear.
Prostaglandin E1 did not inhibit the lipolytic response
of the human cells to DCAMP. This lack of effect would
be expected if PGE1 influenced the lipolytic enzyme system by interfering with the accumulation of cyclic
AMP. Thus, PGE1 should have no effect on the acti-

vation of inactive lipase to active lipase or of glycogen phosphorylase by 3',5'-cyclic adenosine monophos-

phate. It has been suggested that PGE1 might activate
the phosphodiesterase involved in degradation of cyclic
AMP (25). This appears unlikely since DCAMP is degraded by the phosphodiesterase (26) which attacks
cyclic AMP, and if PGE1 activates this enzyme it should
have inhibited the action of DCAMP on human fat cells.
Prostaglandin E, lowered the increases of phosphorylase activity and lipolysis due to the addition of norepinephrine and theophylline. These results confirm
data from animal studies which concluded that PGE1 inhibited the activation of phosphorylase and lipase activity due to catecholamines (27).
From these studies it is evident that the human adipocyte preparation responds in a manner similar to rat
fat cells when challenged with various lipolytic agents.
Norepinephrine, theophylline, and dibutyryl cyclic nucleotide all stimulated both lipolysis and glycogenolysis.
Insulin and prostaglandin E, reduce the stimulation of
both processes by norepinephrine and theophylline but
not by dibutyryl cyclic AMP. The data from the studies with PGE, support the hypothesis that cyclic AMP
is involved in the activation of lipolysis and phosphorylase in human as in rat fat cells and that PGE1
probably acts to inhibit adenyl cyclase.
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